Skip to main content
. 2018 Jul 20;57(11):1982–1990. doi: 10.1093/rheumatology/key206

Table 3.

Predicting response to biologic therapy: improvements in the BASDAI

Baseline variable Model 1 (n = 135), coefficient (95% CI) Model 2 (n = 121), coefficient (95% CI)
Constant −0.99 (−2.72, 0.75) −0.28 (−2.03, 1.48)
BASDAI 0.72 (0.49, 0.95) 0.84 (0.60, 1.08)
BASFI −0.38 (−0.60, −0.17) −0.17 (−0.41, 0.07)
Age (years)
    <30 0 0
    30–39 0.75 (−0.56, 2.07) 0.82 (−0.46, 2.10)
    40–49 0.58 (−0.73, 1.89) 0.29 (−0.98, 1.56)
    50–59 0.31 (−1.11, 1.73) 0.26 (−1.14, 1.66)
    60–69 0.41 (−1.03, 1.86) 0.13 (−1.35, 1.62)
    ≥70 −1.03 (−3.25, 1.19) −0.89 (−3.22, 1.43)
Index of Multiple Deprivation (quintiles)
    1 (highest deprivation) 0 0
    2 0.58 (−0.71, 1.87) 0.66 (−0.68, 2.00)
    3 −0.20 (−1.43, 1.03) −0.50 (−1.79, 0.80)
    4 0.91 (−0.28, 2.11) 0.71 (−0.52, 1.94)
    5 0.55 (−0.67, 1.78) 0.19 (−1.12, 1.49)
Gender
    Male 0 0
    Female −0.61 (−1.38, 0.17) −0.10 (−0.91, 0.70)
Smoking status
    Never 0 0
    Ex-smoker 0.13 (−0.72, 0.98) 0.21 (−0.64, 1.06)
    Current 0.19 (−0.76, 1.13) 0.59 (−0.40, 1.57)
FM criteria met −0.58 (−1.40, 0.23) Not applicable
FM Not applicable
    WPI −0.10 (−0.24, 0.03)
    SSS −0.32 (−0.53, −0.12)

Model 1 fit: R2 = 0.3261; model 2 fit: R2 = 0.4079.